BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

OncoVista Innovative Therapies, Inc. 

14785 Omicron Drive
Suite 104
San Antonio  Texas  78245  U.S.A.
Phone: 210-677-6000 Fax: 210-677-6001


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





 Company News
FDA Approves OncoVista Innovative Therapies, Inc.'s Phase I Clinical Trial of New Drug Candidate (OVI-117) for Solid Tumors 7/10/2012 8:31:23 AM    More...
OncoVista Innovative Therapies, Inc. Engages Oncology Therapeutic Development to Initiate a Phase Ib Study of Cordycepin in Patients With Refractory TdT Positive Leukemia 11/29/2011 7:49:15 AM    More...
OncoVista Innovative Therapies, Inc. Initiates Additional Safety Study of OVI-117 7/13/2011 9:01:59 AM    More...
OncoVista Innovative Therapies, Inc. Sells AdnaGen Subsidiary: Total Sale Price Could Reach $65 Million Over Three Years When Milestones Achieved 11/11/2010 8:13:28 AM    More...
OncoVista Innovative Therapies, Inc. Subsidiary Grants Option to License Proprietary Antibodies to KellBenx Inc. 6/18/2010 11:16:50 AM    More...
OncoVista Innovative Therapies, Inc. Updates with Comprehensive Shareholder Letter 6/15/2010 9:24:20 AM    More...
OncoVista Innovative Therapies, Inc. Reports Sharply Higher Q1 Revenues 5/17/2010 2:40:50 PM    More...
OncoVista Innovative Therapies, Inc. Subsidiary AdnaGen Inks Exclusive Agreement with TATAA Molecular Diagnostics 1/26/2010 9:31:13 AM    More...
OncoVista Innovative Therapies, Inc. Reinstated on the OTC Bulletin Board 12/3/2009 2:32:35 PM    More...
OncoVista Innovative Therapies, Inc. Reports on Gene Expression Profiling Study in Circulating Tumor Cells (CTCs) - a Molecular Tool for Therapy Individualization 11/23/2009 9:56:30 AM    More...
1234

//-->